Effectiveness of CAT-GSH for Returning Patients
Effectiveness and Acceptability of Cognitive Analytic Therapy Guided Self-help (CAT-GSH) for Anxiety and Depression for Returning Patients in NHS Talking Therapies Services
1 other identifier
interventional
100
1 country
2
Brief Summary
The goal of this clinical trial is to learn if cognitive analytic therapy-guided self-help (CAT-GSH) is comparable to cognitive behavioural therapy-guided self-help (CBT-GSH) in terms of whether it is effective and acceptable for people with anxiety or low mood, who are returning to NHS Talking Therapy services for further treatment. The main questions it aims to answer are:
- Does CAT-GSH work well and feel acceptable for people coming back to the Talking Therapies service, compared to CBT-GSH, when taking their characteristics (like age) into account
- Does CAT-GSH work well and feel acceptable for people coming back to the Talking Therapies service, compared to those using CBT-GSH for the first time, when taking their characteristics (like age) into account? Participants will:
- Choose their preferred treatment
- Complete 6 sessions of either CAT-GSH or CBT-GSH
- Sessions will be weekly or bi-weekly
- Complete routine outcome measures before, during and at the end of therapy
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable anxiety
Started Jul 2025
Shorter than P25 for not_applicable anxiety
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 31, 2025
CompletedFirst Posted
Study publicly available on registry
February 3, 2025
CompletedStudy Start
First participant enrolled
July 30, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2025
CompletedOctober 3, 2025
January 1, 2025
4 months
January 31, 2025
September 29, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Composite score (Generalised Anxiety Disorder-7 (GAD-7), Patient health Questionaire-9 (PHQ-9) and Work and Social Adjustment Scale (WSAS))
Routine outcome measures, Generalised Anxiety Disorder-7 (GAD-7), Patient Health Questionaire-9 (PHQ-9) and Work and Social Adjustment Scale (WSAS) collected before, during and after treatment will be combined into composite scores.
From enrolment to the end of treatment after 6 sessions, weekly or bi-weekly. 6-12 weeks.
Secondary Outcomes (2)
Patient Health Questionnaire (PHQ-9)
From enrolment to the end of treatment at 6-12 weeks. Sessions weekly or bi-weekly.
Generalised Anxiety Disorder (GAD-7)
From enrolment to the end of treatment at 6-12 weeks. Sessions weekly or bi-weekly.
Study Arms (2)
CBT-GSH arm
ACTIVE COMPARATORCBT-GSH group
CAT-GSH arm
ACTIVE COMPARATORCAT-GSH group
Interventions
Six session CAT-GSH treatment
Six session CBT-GSH treatment
Eligibility Criteria
You may qualify if:
- Previously received CBT-GSH at same participating NHS Talking Therapies service
- Presenting with anxiety or depression
- Deemed suitable for step 2 low-intensity therapy, through assessment by a qualified PWP
You may not qualify if:
- Previously received high-intensity therapy since receiving CBT-GSH
- The previous treatment episode was in another NHS Talking Therapies service.
- Not fluent in English
- Individuals who are not fluent in English will be excluded from the study due to not having translated CAT-GSH workbooks available and limited funding to translate any workbooks.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Sheffieldlead
- Catalyse CAT Limitedcollaborator
- Tameside and Glossop Talking Therapies servicecollaborator
- Leeds Mental Wellbeing servicecollaborator
Study Sites (2)
Tameside and Glossop NHS Talking Therapies Service
Ashton-under-Lyne, OL6 7SR, United Kingdom
Leeds Mental Wellbeing Service
Leeds, LS9 7TA, United Kingdom
Related Publications (11)
Williams R, Farquharson L, Palmer L, Bassett P, Clarke J, Clark DM, Crawford MJ. Patient preference in psychological treatment and associations with self-reported outcome: national cross-sectional survey in England and Wales. BMC Psychiatry. 2016 Jan 15;16:4. doi: 10.1186/s12888-015-0702-8.
PMID: 26768890BACKGROUNDWakefield S, Delgadillo J, Kellett S, White S, Hepple J. The effectiveness of brief cognitive analytic therapy for anxiety and depression: A quasi-experimental case-control study. Br J Clin Psychol. 2021 Jun;60(2):194-211. doi: 10.1111/bjc.12278. Epub 2021 Jan 17.
PMID: 33458855BACKGROUNDSimmonds-Buckley M, Osivwemu EO, Kellett S, Taylor C. The acceptability of cognitive analytic therapy (CAT): Meta-analysis and benchmarking of treatment refusal and treatment dropout rates. Clin Psychol Rev. 2022 Aug;96:102187. doi: 10.1016/j.cpr.2022.102187. Epub 2022 Jul 18.
PMID: 35914380BACKGROUNDOwen K, Laphan A, Gee B, Lince K. Evaluating cognitive analytic therapy within a primary care psychological therapy service. Br J Clin Psychol. 2023 Sep;62(3):663-673. doi: 10.1111/bjc.12430. Epub 2023 Jun 14.
PMID: 37317047BACKGROUNDMeadows J, Kellett S. Development and Evaluation of Cognitive Analytic Guided Self-Help (CAT-SH) for Use in IAPT Services. Behav Cogn Psychother. 2017 May;45(3):266-284. doi: 10.1017/S1352465816000485. Epub 2017 Mar 22.
PMID: 28325165BACKGROUNDLorimer B, Kellett S, Giesemann J, Lutz W, Delgadillo J. An investigation of treatment return after psychological therapy for depression and anxiety. Behav Cogn Psychother. 2024 Mar;52(2):149-162. doi: 10.1017/S1352465823000322. Epub 2023 Aug 11.
PMID: 37563726BACKGROUNDKellett S, Simmonds-Buckley M, Limon E, Hague J, Hughes L, Stride C, Millings A. Defining the Assessment and Treatment Competencies to Deliver Low-Intensity Cognitive Behavior Therapy: A Multi-Center Validation Study. Behav Ther. 2021 Jan;52(1):15-27. doi: 10.1016/j.beth.2020.01.006. Epub 2020 May 20.
PMID: 33483113BACKGROUNDHallam C, Simmonds-Buckley M, Kellett S, Greenhill B, Jones A. The acceptability, effectiveness, and durability of cognitive analytic therapy: Systematic review and meta-analysis. Psychol Psychother. 2021 Mar;94 Suppl 1:8-35. doi: 10.1111/papt.12286. Epub 2020 Jun 15.
PMID: 32543107BACKGROUNDBohnke JR, Lutz W, Delgadillo J. Negative affectivity as a transdiagnostic factor in patients with common mental disorders. J Affect Disord. 2014 Sep;166:270-8. doi: 10.1016/j.jad.2014.05.023. Epub 2014 May 27.
PMID: 25012441BACKGROUNDWray A, Kellett S, Bee C, Smithies J, Aadahl V, Simmonds-Buckley M, McElhatton C. The acceptability of cognitive analytic guided self-help in an Improving Access to Psychological Therapies service. Behav Cogn Psychother. 2022 Sep;50(5):493-507. doi: 10.1017/S1352465822000194. Epub 2022 May 16.
PMID: 35575218BACKGROUNDKellett S, Bee C, Smithies J, Aadahl V, Simmonds-Buckley M, Power N, Dugen-Williams C, Fallon N, Delgadillo J. Cognitive-behavioural versus cognitive-analytic guided self-help for mild-to-moderate anxiety: a pragmatic, randomised patient preference trial. Br J Psychiatry. 2023 Sep;223(3):438-445. doi: 10.1192/bjp.2023.78.
PMID: 37395600BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Andrew J Laphan
University of Sheffield
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 31, 2025
First Posted
February 3, 2025
Study Start
July 30, 2025
Primary Completion
December 1, 2025
Study Completion
December 1, 2025
Last Updated
October 3, 2025
Record last verified: 2025-01
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL
- Time Frame
- At the end of the study (approximately May 2026), data will be stored on the University of Sheffield's ORDA (online research hub) for 10 years according to the University of Sheffield's retention period.
- Access Criteria
- Information can be requested through ORDA by those who qualify for membership.
Only anonymized data will be shared. Personal data will not be.